GLUT1 and CAIX were significantly upregulated in aggressive breast cancer subtypes and strongly associated with poor prognostic factors, including high tumour grade, hypoxic tumour microenvironment, and increased metabolic reprogramming [98]. The gene discussed is CA9; the disease is breast carcinoma.